CMS Proposes Permanent CLIA Virtual Access for Remote Lab Review
A proposed rule would let pathologists review digital slides under one CLIA certificate without separate site filings.
CMS published a proposed rule on October 8, 2026 that would permanently allow pathologists and laboratory personnel to review digital laboratory data, results, and images remotely under the CLIA certificate of the primary testing laboratory that generated the data 1. The move codifies enforcement discretion CMS exercised during and after the COVID-19 public health emergency, removing a structural barrier for digital pathology, remote diagnostic networks, and tele-laboratory software.
Key takeaways - CMS proposes to let laboratories operate remote review sites under a single primary CLIA certificate, except for the cytology subspecialty 1. - The rule would eliminate the need for separate facility certifications for remote reviewer workstations, enabling distributed diagnostic workflows 1. - Comments are due by December 7, 2026, and the rule also addresses personnel qualifications, gynecologic cytology proficiency testing, and SARS-CoV-2 reporting removal 1.
What the proposed rule changes
Current CLIA regulations require a separate certificate application for each laboratory location unless an exception applies 1. During the SARS-CoV-2 public health emergency, CMS issued memo QSO-20-21-CLIA allowing pathologists to review digital data, results, and pathology slides remotely under the primary site’s certificate 1. After the PHE ended on May 11, 2023, CMS extended this flexibility through memo QSO-23-15-CLIA, listing nine criteria laboratories had to meet — including primary lab director responsibility, HIPAA compliance, and test reports indicating the remote site location 1.
On September 23, 2025, CMS issued QSO-23-15-CLIA-REVISED, which, in part, discontinued the temporary exercise of enforcement discretion 1. This proposed rule would replace that patchwork with a permanent regulatory framework. The core change: virtual access would be permitted under the primary laboratory’s CLIA certificate for all specialties and subspecialties except cytology, where slide preparations must still be evaluated on the premises of a cytology-certified laboratory per section 353(f)(4)(B)(vi) of the Public Health Service Act 1.
Why cytology is excluded
The statute explicitly requires cytology screening and slide preparations to be evaluated on the premises of a laboratory certified in the cytology subspecialty 1. The proposed rule respects that statutory limitation while allowing digital images of glass slides to be used for gynecologic cytology proficiency testing — aligning with FDA-authorized digital cytology screening systems 1. This distinction matters for labs building remote workflows: they can distribute most diagnostic review but must keep cytology review on-site or at a separately certified cytology lab.
Personnel qualification updates
The proposal also addresses workforce concerns by modifying personnel qualification requirements that took effect December 28, 2024 1. It would remove human-only laboratory science limitations and add qualifications for histopathology gross tissue examination personnel and Mohs dermatology laboratory directors 1. These changes respond to feedback that the 2024 requirements created unnecessary barriers amid ongoing workforce shortages.
Other notable provisions
Beyond virtual access, the rule proposes to: - Remove SARS-CoV-2 reporting requirements that are no longer needed 1 - Update certificate requirements and test reporting requirements 1 - Revise enforcement requirements and public consultation requirements, including regulatory text establishing the Clinical Laboratory Improvement Advisory Committee (CLIAC) 1 - Correct editorial and technical errors throughout 42 CFR Part 493 1
What the enforcement data showed
CMS reviewed survey citations from March 1, 2023 to July 1, 2024 — the year following the post-PHE memo — searching for citations related to “remote” or “digital” review 1. The agency identified no concerning citation trends, supporting the case that remote review does not decrease accuracy of test results 1.
What this means in practice
For digital pathology and tele-laboratory vendors: You can now design architectures where a single primary CLIA certificate covers remote pathologist workstations, home-based reviewers, and distributed reading rooms — without each location filing a separate application. Build your audit trails and access controls to satisfy the proposed requirements: primary lab director responsibility, HIPAA compliance, test reports indicating remote site (coding system acceptable), and personnel listed on the primary lab’s Form CMS-209 1.
For laboratory directors and compliance officers: Map your current remote review arrangements against the nine criteria from QSO-23-15-CLIA; those become the regulatory baseline. Prepare to update policies for test reporting, personnel tracking, and documentation retention. The cytology exception means any remote gynecologic cytology review still requires a separately certified cytology lab — plan workflows accordingly.
For health-system IT and informatics leads: This rule enables enterprise-wide digital pathology deployments under one CLIA certificate. Coordinate with your lab directors to ensure LIS and image management systems can tag remote review locations and maintain the documentation chain the rule requires.
Timeline: Comments due December 7, 2026 1.
Our read: This is the clearest signal yet that CMS treats distributed diagnostic workflows as permanent infrastructure, not pandemic contingency. The cytology carve-out reflects statutory text, not policy preference — expect pressure to amend the Public Health Service Act if digital cytology validation continues. For teams building remote diagnostic networks, the compliance target is now visible: design to the nine criteria, document everything, and treat the primary lab’s certificate as the single source of truth.
Sources
- Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes — Federal Register, 2026-10-08
- Lawmakers press CMS to roll back proposed restrictions on remote patient monitoring - Fierce Healthcare — fiercehealthcare.com, 2026-10-06
- Fragmented state AI rules could slow patient access - MobiHealthNews — mobihealthnews.com, 2026-10-08
- Why AI could make it harder to switch EHR vendors - Modern Healthcare — modernhealthcare.com, 2026-10-13
Researched and drafted with AI from the sources above, and checked claim by claim against them before publishing.